Get the Stockscreener App
36.37
0.01%
-0.05
After Hours:
36.37
Amphastar Pharmaceuticals Inc stock is traded at $36.37, with a volume of 419.50K.
It is down -0.01% in the last 24 hours and down -1.15% over the past month.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$36.42
Open:
$36.42
24h Volume:
419.50K
Relative Volume:
0.83
Market Cap:
$1.77B
Revenue:
$723.55M
Net Income/Loss:
$157.72M
P/E Ratio:
12.12
EPS:
3
Net Cash Flow:
$170.15M
1W Performance:
+0.07%
1M Performance:
-1.15%
6M Performance:
-16.33%
1Y Performance:
-33.72%
1-Day Range:
$36.06
$37.04
1-Week Range:
$35.79
$37.66
52-Week Range:
$34.60
$56.45
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Compare AMPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
36.37 | 1.77B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
172.80 | 78.39B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.69 | 43.65B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
HLN
Haleon Plc Adr
|
9.57 | 43.41B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.83 | 20.07B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
153.29 | 15.53B | 2.24B | 385.90M | 440.10M | 3.73 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-22-24 | Initiated | Wells Fargo | Equal Weight |
| Mar-05-24 | Initiated | JP Morgan | Overweight |
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Pacer Advisors Inc. Has $50.14 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Technical Data - Stock Traders Daily
Possible Bearish Signals With Amphastar Pharmaceuticals Insiders Disposing Stock - Simply Wall St
Assenagon Asset Management S.A. Sells 5,956 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Short Interest Up 10.3% in December - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowTime to Sell? - MarketBeat
Amphastar stock hits 52-week low at $34.6 amid market challenges - MSN
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 2.4%Should You Sell? - MarketBeat
Dextrose Injection Market Size, Share & Trending Opportunities - WICZ
Dextrose Injection Market Size, Share & Trending Opportunities (2024-2031) | Pfizer Inc., Amphastar Pharmaceuticals Inc. - EIN News
Trend Tracker for (AMPH) - Stock Traders Daily
Oversold Conditions For Amphastar Pharmaceuticals (AMPH) - Nasdaq
Amphastar stock hits 52-week low at $34.85 amid market challenges - Investing.com Nigeria
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Up 4.6%What's Next? - MarketBeat
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - AccessWire
Amphastar stock hits 52-week low at $34.85 amid market challenges By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals: Cheap With Caveats (NASDAQ:AMPH) - Seeking Alpha
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Expands By 6.1% - Defense World
Short Interest in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Increases By 6.1% - MarketBeat
Amphastar stock hits 52-week low at $36.55 amid market challenges - Investing.com Australia
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 1-Year LowHere's Why - MarketBeat
Amphastar stock hits 52-week low at $36.55 amid market challenges By Investing.com - Investing.com South Africa
Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
New Strong Sell Stocks for December 31st - Yahoo Finance
Principal Financial Group Inc. Lowers Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Boosted by Sanctuary Advisors LLC - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Down 2.6%Time to Sell? - MarketBeat
Geode Capital Management LLC Has $44.67 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Geode Capital Management LLC Grows Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Trading Report - Stock Traders Daily
Barclays PLC Buys 25,878 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
19,723 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Bought by Wellington Management Group LLP - MarketBeat
Hyaluronidase Market Massive Growth Predicted (2024-2031) | - openPR
Amphastar Pharmaceuticals executive sells shares worth $672,815 By Investing.com - Investing.com Australia
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 7,000 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals executive sells shares worth $672,815 - Investing.com
Amphastar Pharmaceuticals Enters Oversold Territory (AMPH) - Nasdaq
Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Prospects Need A Boost To Lift Shares - Simply Wall St
World Investment Advisors LLC Takes $1.61 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Trading Down 5.4%What's Next? - MarketBeat
XTX Topco Ltd Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
The Manufacturers Life Insurance Company Trims Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Decreased by Centiva Capital LP - MarketBeat
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amphastar Pharmaceuticals Inc Stock (AMPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 12 '24 |
Option Exercise |
11.33 |
7,000 |
79,310 |
125,469 |
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 13 '24 |
Sale |
45.23 |
8,000 |
361,840 |
118,469 |
| Zhou Rong | SENIOR EVP, PRODUCTION CENTER |
Dec 12 '24 |
Sale |
44.42 |
7,000 |
310,975 |
118,469 |
| PRINS RICHARD K | Director |
Dec 09 '24 |
Option Exercise |
19.52 |
10,000 |
195,200 |
40,471 |
| PRINS RICHARD K | Director |
Dec 09 '24 |
Sale |
43.77 |
10,000 |
437,702 |
30,471 |
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):